What is Cell Science Systems?
Cell Science Systems operates as a specialized clinical laboratory, focusing on advanced testing in immunology, cell biology, and molecular diagnostics. The company is dedicated to advancing personalized treatment and prevention strategies for chronic diseases. Its operations are anchored by a CLIA-certified laboratory and adherence to stringent FDA-inspected, cGMP medical device manufacturing standards, compliant with ISO EN13485. Cell Science Systems is particularly recognized for its pioneering Alcat Test®, a diagnostic tool for identifying food and chemical sensitivities. The company also maintains a wholly-owned subsidiary in Europe, extending its reach and impact globally.
How much funding has Cell Science Systems raised?
Cell Science Systems has raised a total of $813K across 2 funding rounds:
Debt
$350K
Debt
$463K
Debt (2020): $350K with participation from PPP
Debt (2021): $463K led by PPP
What's next for Cell Science Systems?
The recent major strategic investment signals a period of accelerated growth and development for Cell Science Systems. This capital infusion is expected to fuel further innovation in its diagnostic testing capabilities, potentially expanding the scope of the Alcat Test® and other proprietary assays. The company's focus on personalized medicine and chronic disease management positions it for significant expansion within the healthcare and biotechnology markets. Future endeavors will likely involve scaling laboratory operations, enhancing research and development efforts, and potentially broadening its European presence, leveraging the strategic financing to solidify its market leadership.
See full Cell Science Systems company page
